Nuclear haematology is the study of the pathophysiology, diagnosis, and treatment of haematological conditions using radionuclides or radiopharmaceutical substances. Radionuclides are currently commonly employed to label produced blood elements (random labels) in order to track their biological distribution, function, and lifespan in vivo, as well as to examine the proliferation and differentiation of hematopoietic progenitor and precursor cells in the bone marrow (cohort labels). The assessment of spleen size, splenic sequestration of blood cells, and investigations into the absorption, metabolism, and use of haematological nutrients such as iron, vitamin B12, and folate are some of the other primary applications of nuclear haematology. Many imaging techniques are progressively being used and studied to establish the anatomical distribution of hematopoietic tissues in the bone marrow and other organs, as well as to assess their importance in the diagnosis and therapy of various haematological illnesses.
Title : Single cell multi-omics in PBMC’s
Peter J Van Der Spek, Erasmus University Medical Center, Netherlands
Title : Myeloid neoplasms and molecular genetic alterations (Germline vs Somatic) that characterize specific entities in pediatric patients
Aida I Richardson, Ann & Robert H. Lurie Children's Hospital of Chicago, United States
Title : Overview of 2021 guidelines on the diagnosis of Von Willebrand Disease (VWD)
Maryam Asif, University of Washington, United States
Title : Clonal evolution in children with inherited bone marrow failure syndromes
Raykina Elena, Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology, Russian Federation
Title : Defining the clinical contribution of platelet-derived FXIII-A to regulation of fibrinolysis
Fahad S Alshehri, King Faisal Medical City for Southern Region, Saudi Arabia
Title : Multiple alloantibodies: The strategy for identifying antibodies and transfusion management
Ahmed Alharbi, King Abdulaziz Medical City, Saudi Arabia